The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
Publication
, Journal Article
Expert Consensus Panel; Kidane, B; Bott, M; Spicer, J; Backhus, L; Chaft, J; Chudgar, N; Colson, Y; D'Amico, TA; David, E; Lee, J; Najmeh, S ...
Published in: J Thorac Cardiovasc Surg
September 2023
Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
September 2023
Volume
166
Issue
3
Start / End Page
637 / 654
Location
United States
Related Subject Headings
- United States
- Thoracic Surgery
- Small Cell Lung Carcinoma
- Respiratory System
- Neoplasm Staging
- Neoadjuvant Therapy
- Lung Neoplasms
- Immunotherapy
- Humans
- Consensus
Citation
APA
Chicago
ICMJE
MLA
NLM
Expert Consensus Panel, Kidane, B., Bott, M., Spicer, J., Backhus, L., Chaft, J., … Stiles, B. (2023). The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg, 166(3), 637–654. https://doi.org/10.1016/j.jtcvs.2023.04.039
Expert Consensus Panel, Biniam Kidane, Matthew Bott, Jonathan Spicer, Leah Backhus, Jamie Chaft, Neel Chudgar, et al. “The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.” J Thorac Cardiovasc Surg 166, no. 3 (September 2023): 637–54. https://doi.org/10.1016/j.jtcvs.2023.04.039.
Expert Consensus Panel, Kidane B, Bott M, Spicer J, Backhus L, Chaft J, et al. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Sep;166(3):637–54.
Expert Consensus Panel, et al. “The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.” J Thorac Cardiovasc Surg, vol. 166, no. 3, Sept. 2023, pp. 637–54. Pubmed, doi:10.1016/j.jtcvs.2023.04.039.
Expert Consensus Panel, Kidane B, Bott M, Spicer J, Backhus L, Chaft J, Chudgar N, Colson Y, D’Amico TA, David E, Lee J, Najmeh S, Sepesi B, Shu C, Yang J, Swanson S, Stiles B. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2023 Sep;166(3):637–654.
Published In
J Thorac Cardiovasc Surg
DOI
EISSN
1097-685X
Publication Date
September 2023
Volume
166
Issue
3
Start / End Page
637 / 654
Location
United States
Related Subject Headings
- United States
- Thoracic Surgery
- Small Cell Lung Carcinoma
- Respiratory System
- Neoplasm Staging
- Neoadjuvant Therapy
- Lung Neoplasms
- Immunotherapy
- Humans
- Consensus